UK Medicines Information
Committee for Medicinal Products for Human Use (CHMP) recommends approval of clopidogrel / acetylsalicylic acid (Mylan) for secondary prevention of atherothrombotic events
Information type:
Media and commentaries
Source:
European Medicines Agency
Specialities:
Cardiovascular system disorders | Haematological disorders
Summary
Clopidogrel/Acetylsalicylic acid Mylan is a bioequivalent generic of DuoPlavin, which has been authorised in the EU since 15 March 2010. It will be available as film-coated tablets (75 mg clopidogrel with 75 or 100 mg acetylsalicylic acid).
UKMi comment
Neither DuoPlavin or Clopidogrel/Acetylsalicylic acid Mylan are currently licensed in the UK.
Related links: